Search
for
Sort by
Research 781–810 of 1000+
- Exploring links between acne and metabolic syndrome: a narrative review
- Relationship between glucose homeostatic disorders and testosterone in adult Nigerian women with polycystic ovary syndrome
- Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
- Cutaneous manifestations of endocrine diseases in children
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- 8368 Functional Evaluation Of Novel CYP21A2 Variants: Expanding The Genetic Basis Of Non-classic CAH
- 9209 Functional Evaluation Of Novel CYP21A2 Variants: Expanding The Genetic Basis Of Non-classic CAH
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Redefining Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications for Diagnosis, Pathophysiology and Clinical Management
- Síndrome dos ovários policísticos: correlação dos fenótipos com as manifestações metabólicas
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Diagnostic imaging in congenital adrenal hyperplasia – how does it help?
- Prevalence and Metabolic Characterization of Polycystic Ovary Syndrome in a Cohort of Patients Diagnosed with Spina Bifida: Study Protocol
- Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- Integrated Multi-Omics Analysis Reveals Dysregulated Lipid Metabolism as a Novel Mechanism in Androgenetic Alopecia
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Investigating metabolic syndrome markers and body mass index changes in patients with acne vulgaris treated with isotretinoin: A prospective study